Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Permanent Neonatal Diabetes Mellitus
Interventions
DRUG

Sulfonylurea

See Arm description.

Trial Locations (1)

5021

Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

University of Bergen

OTHER

collaborator

University of Exeter

OTHER

collaborator

Royal Devon and Exeter NHS Foundation Trust

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Hôpital Necker-Enfants Malades

OTHER

collaborator

University of Rome Tor Vergata

OTHER

lead

Haukeland University Hospital

OTHER

NCT02624817 - Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes | Biotech Hunter | Biotech Hunter